India to New Zealand: Ipratropium Export Trade Route
India has recorded 30 verified shipments of Ipratropium exported to New Zealand, representing a combined trade value of $588.8K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $19.6K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 83% of total export value with 22 shipments worth $486.1K USD. On the buying side, REX MEDICAL LTD, is the largest importer in New Zealand with $218.4K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to New Zealand Ipratropium corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $588.8K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 83% of all export value, reflecting the consolidated nature of India's ipratropium manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $19.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 18.4%, placing it at rank #3 among India's top ipratropium export destinations globally.
On the import side, key buyers of Indian ipratropium in New Zealand include REX MEDICAL LTD,, REX MEDICAL LTD, REX MEDICAL LTD, and 2 others. REX MEDICAL LTD, is the single largest importer with 4 shipments valued at $218.4K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portSAHAR AIR
Market Position
- Global rank#3
- Annual growth+18.4%
- Demand growth+15.8%
- Regulatory ease67/100
Top 10 Indian Ipratropium Exporters to New Zealand
Showing top 10 of 2 Indian suppliers exporting Ipratropium to New Zealand, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $22.1K per shipment | 22 | $486.1K | 82.5% |
| 2 | CIPLA LIMITED Avg $12.8K per shipment | 8 | $102.8K | 17.5% |
This table shows the top 10 of 2 Indian companies exporting ipratropium to New Zealand, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED . CIPLA LIMITED is the dominant supplier with 22 shipments worth $486.1K USD, giving it a 83% market share.
Top 10 Ipratropium Importers in New Zealand
Showing top 10 of 5 known buyers in New Zealand receiving Ipratropium shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ipratropium in New Zealand include REX MEDICAL LTD,, REX MEDICAL LTD, REX MEDICAL LTD, , REX MEDICAL LIMITED, REX MEDICAL LTD . The largest importer is REX MEDICAL LTD,, accounting for $218.4K USD across 4 shipments — representing 37% of all ipratropium imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | REX MEDICAL LTD, | 4 | $218.4K | 37.1% |
| 2 | REX MEDICAL LTD | 13 | $211.1K | 35.9% |
| 3 | REX MEDICAL LTD, | 7 | $85.5K | 14.5% |
| 4 | REX MEDICAL LIMITED | 5 | $56.5K | 9.6% |
| 5 | REX MEDICAL LTD | 1 | $17.3K | 2.9% |
Top 10 Ipratropium Formulations Imported by New Zealand
Showing top 10 of 23 product formulations shipped on the India to New Zealand Ipratropium route, ranked by trade value
New Zealand imports a wide range of ipratropium formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — UNIVENT NASAL SPRAY (IPRATROPIUM BROMIDE NASAL SOLUTION 0.03%W/V (21MCG/MD)) (1X15 ML) — accounts for $142.1K USD across 2 shipments. There are 23 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UNIVENT NASAL SPRAY (IPRATROPIUM BROMIDE NASAL SOLUTION 0.03%W/V (21MCG/MD)) (1X15 ML) | 2 | $142.1K | 24.1% |
| 2 | DUOLIN HFA INHALER (SALBUTAMOL SULPHATE 100MCG + IPRATROPIUM BROMIDE20 MCG). | 6 | $70.3K | 11.9% |
| 3 | UNIVENT NASAL SPRAY (IPRATROPIUM BROMIDE NASAL SOLUTION 0.03%W/V (21MCG/MD)) (1 X 15 ML) | 1 | $64.8K | 11.0% |
| 4 | UNIVENT NASAL SPRAY IPRATROPIUM BROMIDE NASAL SOLUTION 0.03%W/V (21MCG/MD) (1 X 15 ML) | 1 | $59.5K | 10.1% |
| 5 | DUOLIN HFA INHALER (SALBUTAMOL SULPHATE100MCG+ IPRATROPIUM BROMIDE 20MCG )(3029 PACKS)(1X200MD/PACKS) | 2 | $22.3K | 3.8% |
| 6 | DUOLIN RESPULES 2.5MLIPRATROPIUM BROMID | 1 | $18.6K | 3.2% |
| 7 | DUOLIN RESPULES 2.5ML IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG PER2.5ML RESPULES INV.QTY.1488 PACK 12X5 | 1 | $18.1K | 3.1% |
| 8 | DUOLIN RESPULES 2.5ML IPRATROPIUM BROMI | 1 | $18.1K | 3.1% |
| 9 | DUOLIN CIPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML)RESPULES)(5120 PACKX4X5=102400 NOS)(2.5ML) | 1 | $17.6K | 3.0% |
| 10 | UNIVENT 500MCG/2ML (IPRATROPIUM BROMIDE | 1 | $17.3K | 2.9% |
Showing top 10 of 23 Ipratropium formulations imported by New Zealand on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 66% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
SAHAR AIR handles the highest volume with 10 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's ipratropium exports to New Zealand are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 22 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in New Zealand benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED — together account for 100% of total trade value on this route. The average shipment value of $19.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as duolin hfa inhaler (salbutamol sulphate 100mcg + ipratropium bromide20 mcg). and univent nasal spray (ipratropium bromide nasal solution 0.03%w/v (21mcg/md)) (1 x 15 ml), suggesting that buyers in New Zealand tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, REX MEDICAL LTD, is the largest importer with 4 shipments worth $218.4K USD — representing 37% of all ipratropium imports from India on this route.
Route Statistics
- Trade Volume
- $588.8K
- Avg. Shipment
- $19.6K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~18 days
- Annual Growth
- +18.4%
Related Analysis
Other Ipratropium Routes
Unlock the Full India to New Zealand Ipratropium Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 30 shipments on this route.
Frequently Asked Questions — India to New Zealand Ipratropium Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ipratropium to New Zealand?
The leading Indian exporters of Ipratropium to New Zealand are CIPLA LIMITED, CIPLA LIMITED . CIPLA LIMITED holds the largest market share at approximately 83% of total trade value on this route.
Q What is the total value of Ipratropium exports from India to New Zealand?
India exports Ipratropium to New Zealand worth approximately $588.8K USD across 30 recorded shipments. The average value per shipment is $19.6K USD.
Q Which ports does India use to ship Ipratropium to New Zealand?
The most active port of origin is SAHAR AIR with 10 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 66% of shipments going by sea and 16% by air.
Q How long does shipping take from India to New Zealand for Ipratropium?
The average transit time for Ipratropium shipments from India to New Zealand is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to New Zealand Ipratropium trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.4% with demand growth tracking at 15.8%. The route is ranked #3 among India's top Ipratropium export destinations globally.
Q How many suppliers are active on the India to New Zealand Ipratropium route?
There are currently 2 active Indian suppliers exporting Ipratropium to New Zealand. The market is moderately concentrated with CIPLA LIMITED accounting for 83% of total shipment value.
Q Who are the main importers of Ipratropium from India in New Zealand?
The leading importers of Indian Ipratropium in New Zealand include REX MEDICAL LTD,, REX MEDICAL LTD, REX MEDICAL LTD, , REX MEDICAL LIMITED, REX MEDICAL LTD . REX MEDICAL LTD, is the largest buyer with 4 shipments worth $218.4K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to New Zealand export trade corridor identified from Indian Customs (DGFT) records for Ipratropium.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in New Zealand matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 30 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
30 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists